Supramolecular nanostructures formed by anticancer drug assembly

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Therapeutics

Background:

• Hydrophobic anticancer drugs like camptothecin (CPT) face challenges in formulation and delivery.
• Developing stable, high-loading drug delivery systems is crucial for effective cancer treatment.

Purpose of the Study:

• To develop a supramolecular strategy for assembling camptothecin (CPT) into well-defined nanostructures.
• To investigate the drug loading, stability, and controlled release properties of these nanostructures.
• To evaluate the in vitro efficacy of CPT nanostructures against cancer cell lines.

Main Methods:

• Supramolecular self-assembly of camptothecin (CPT) using a biodegradable linker.
• Characterization of nanostructure morphology (nanofibers, nanotubes) and drug loading content (23-38%).
• In vitro drug release studies under tumor-relevant conditions and cytotoxicity assays.

Main Results:

• Successfully assembled CPT into stable nanofibers or nanotubes with high, quantitative drug loading.
• Nanostructure formation protected CPT and the linker, enabling controlled drug release.
• CPT nanostructures demonstrated in vitro efficacy against various cancer cell lines.

Conclusions:

• This supramolecular strategy enables the direct assembly of hydrophobic anticancer drugs into self-delivering nanostructures.
• The developed nanostructures offer enhanced drug protection, controlled release, and potent anticancer activity.
• The approach is extendable to other anticancer drugs, presenting new avenues for cancer therapeutics.